Key facts
- This page summarizes Hao-Yuan Chuang's Form 4 filing for BELITE BIO, INC (BLTE).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 30 Oct 2026, 21:00.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Other
No transaction description listed
Additional SEC filing notes
Footnote F1
On September 15, 2025, the reporting person was granted an award of restricted stock units ("RSUs") which shall vest upon satisfaction of several performance criteria. Certain of these performance criteria were met on 10/29/2026, resulting in vesting of the RSUs as to 5,000 ordinary shares.
Footnote F2
Excludes 30,000 ordinary shares previously reported as directly owned, which the reporting person transferred on June 8, 2026 to ESHJ Ltd, a company wholly beneficially owned by the reporting person.